Arcutis Biotherapeutics, Inc. (ARQT)

26.31 +0.90 (+3.52%) USD  |  NASDAQ  |  Feb 23, 16:00
26.30 -0.01 (-0.04%) After-Hours: 07:53
More

Arcutis Biotherapeutics Capital Expenditures (TTM)

Capital Expenditures (TTM) Chart

View Capital Expenditures (TTM) for ARQT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Capital Expenditures (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Capex Definition

View Capex Definition
Start Trial

Capital expenditures are a line item from a company's statement of cash flows.

Read full definition.

Capital Expenditures (TTM) Range, Past 5 Years

View Capital Expenditures (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Capital Expenditures (TTM) Benchmarks

View Capital Expenditures (TTM) Benchmarks
Start Trial
CorMedix, Inc. Upgrade
ADMA Biologics, Inc. Upgrade
ANI Pharmaceuticals, Inc. Upgrade
Amicus Therapeutics, Inc. Upgrade
Pacira Biosciences, Inc. Upgrade